Erlonat 100 mg Tablet
  1. Home
  2. Pharma Products
  3. Natco Pharma Ltd
  4. Erlonat 100 mg Tablet

Erlonat 100 mg Tablet

Erlonat 100 mg Tablet contains erlotinib 100 mg, a targeted anticancer medicine that inhibits epidermal growth factor receptor (EGFR) signaling. It is used for non-small cell lung cancer and pancreatic cancer. The tablet is taken orally on an empty stomach as prescribed by a qualified healthcare professional.

BUY NOW

Category

Erlotinib blocks EGFR tyrosine kinase activity, helping interfere with signals that promote the growth and spread of certain cancer cells. It may be prescribed according to the cancer type, disease stage, and treatment plan established by the oncologist. Treatment may require monitoring for skin rash, diarrhea, liver-related effects, and other adverse reactions. Food can affect erlotinib absorption, so the medicine should be taken according to the prescribed timing in relation to meals.

Technical Specification

Specification Details
Active Ingredient Erlotinib
Strength 100 mg
Dosage Form Film-Coated Tablet
Route of Administration Oral
Pack Size 30 Tablets
Manufacturer / Marketer Natco Pharma Ltd

Product Also Known As

Erlonat 100 mg Tablet, Erlonat 100mg Tablet, Erlonat 100 Tablet, Erlotinib 100 mg Tablet, Erlotinib 100mg Tablet, Erlotinib Hydrochloride 100 mg Tablet, Erlotinib Anticancer Tablet